Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results

PaperCitations, authors & open-access status

Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 91 citations, 2021 year and hybrid oa status.

91
Citations
2021
Year
hybrid
OA Status

Related on ScholarIQ

Tahir Shah
Author
Ulrich F. Pape
Author
European Journal of Cancer
Journal
Neuroendocrine Tumor Research Advances
Topic
Neuroendocrine Tumor Research Advances
Topic
Pancreatic and Hepatic Oncology Research
Topic
470M+ articles · free account